News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Elsbernd Brian
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/22/2023 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $16.069, valued at
$803.5k
Exercised 50,000 options to buy
@ $1.13, valued at
$56.5k
|
|
| 12/29/2022 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 69,000 options to buy
@ $18.59, valued at
$1.3M
Granted 20,000 restricted stock units
@ $0 |
|
| 12/08/2022 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 14,667 restricted stock units
@ $0 |
|
| 11/15/2022 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 14,666 shares
@ $16.235, valued at
$238.1k
Exercised 65,000 options to buy
@ $1.85, valued at
$120.3k
Exercised 40,000 options to buy
@ $0.79, valued at
$31.6k
|
|
| 02/16/2022 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 29,000 restricted stock units
@ $0 |
|
| 12/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 14,666 shares
@ $0
Granted 14,666 restricted stock units
@ $0 |
|
| 12/04/2019 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 132,000 options to buy
@ $4.64, valued at
$612.5k
Granted 44,000 restricted stock units
@ $0 |
|
|
|